Dr. Lance Eliot, an expert on AI & Law currently serving as a Stanford Fellow, argues that while the new US AI Bill of Rights is not a game changer, it is a step in the right direction...
What rights should we have in a society increasingly being scrutinized, monitored, and controlled via the use of Artificial Intelligence (AI)?
Thats a good question.
To address this thorny and unresolved legal issue, the US White House released on October 4, 2022, a white paper informally referred to as anAI Bill of Rights, which more officially is entitled Blueprint for an AI Bill of Rights: Making Automated Systems Work for the American People. The document is the work of the Office of Science and Technology Policy (OSTP), a federal entity that was established in the mid-1970s and serves to advise the American President and the US Executive Office on various technological, scientific, and engineering aspects of national importance.
Lets unpack the AI Bill of Rights and examine the pros and cons of this latest pronouncement pertaining to AI and the law.
Rightfully Thinking About AI And Human Rights
The naming of this as an AI Bill of Rights is a bit askew since it might inadvertently suggest that these are rights associated with AI systems that are considered reaching sentience or otherwise nearing a point of legal personhood. Not so. To clarify, this 73-page long document is abouthuman rightsamid the ongoing onslaught of AI systems that are being deployed without sufficient attention to humankinds safety and well-being.
You might be aware that AI has been put into use by numerous private and public organizations and has ended up acting in a variety of discriminatory ways. Our civil rights and civil liberties are under attack by how AI is crafted and utilized. AI at times is ruinously undercutting data privacy. AI permeates all manner of social media and can wrongfully suppress the speech of those criticizing hate speech, ironically so. AI can be used to stalk someone across both electronic and physical worlds, endangering their personal safety.
On and on, the litany of AI endangerment goes.
A technical companion portion within the AI Bill of Rights describes dozens of real-world examples showcasing how AI is being improperly devised and fostering potential harm. The examples suffice to get the hair standing on the back of your neck. As an additional harbinger of concern, keep in mind that AI is expansively being rolled out and will ultimately be ubiquitous. You can anticipate a non-stop barrage of AI amidst nearly all of our daily apps on our smartphones and likewise AI-powered applications used by major companies and by governmental agencies.
If we are inexorably going to be immersed in an AI-permeated way of existence, the logical response is to stand up for the rights of humankind. Thus, the reasoned basis to forge an AI Bill of Rights that can valiantly protect people.
The US Constitution famously has a historic Bill of Rights that includes vital guarantees of personal freedoms and mindfully addresses the codification of legally stipulated rights. The first ten amendments of the Constitution are breathtaking in their scope and significance. This AI Bill of Rights attempts to leverage the revered nature of the Bill of Rights to draw public attention to what needs to be considered in an AI era (some might readily criticize trying to somewhat exploit the famed Bill of Rights in this naming manner, perhaps overstepping a proper sense of decorum, though it could be a small price to pay for engaging society in the upcoming AI legal morass).
The AI Bill of Rights posits five keystones (excerpts quoted from the official white paper as cited earlier):
AI that is programmed by humans can contain a plethora of hidden risks.
I am not alluding to existential risks such as AI that rises and takes over humanity (we arent yet in that ballpark). The kind of AI that is being confronted consists of non-sentient algorithmic AI. Efforts to legislatively contend with algorithmic AI include the U.S. Congressional ongoing efforts toward crafting the Algorithmic Accountability Act, while in the European realm there is the EU Artificial Intelligence Act (AIA) currently under review.
An Appetizer But Not A Meal
You would be hard-pressed to argue against the proposed precepts of the newly unveiled AI Bill of Rights. The five keystones are indubitably sensible. It is possible to quibble with some of the wording here or there, but overall, the indicated protections are what we need to be diligently considering.
That being said, the AI Bill of Rights has perhaps only whetted our appetite. Envision that this is the precursor or appetizer leading up to a fuller meal.
We have already seen this appetizer in other guises, such as the US Department of Defense (DoD) officially statedEthical Principles of AI and even the somewhat comparabledirectivesby the Vatican in itsRome Call For AI Ethics. A much more extensive elucidation of these types of AI-relevant humankind rights was well-documented in theRecommendation on the Ethics of Artificial Intelligence released last year by UNESCO (United Nations Educational, Scientific, and Cultural Organization) which garnered adopted approval by 193 member countries of the United Nations [8].
In that sense, the AI Bill of Rights has a lot to draw upon and yet also measure up to.
The AI Bill of Rights can be said to be insufficient in many ways, including but not limited to:
Despite those aforementioned insufficiencies, there is certainly something to be said about trying to place a stick in the ground and get the ball rolling on the regulatory governance of AI. Apparently, selected areas of the U.S. federal government will attempt to try out the five keystones of the AI Bill of Rights (as suggested in the white paper as part of leading by example). The belief seems to be that this will illuminate the efficacy of the keystones and reveal ways to bolster and sharpen them.
Lawmakers are ultimately going to be in the drivers seat on all of this.
Those tasked with making our laws are going to be immensely challenged with the complicated chore of bringing together a veritable smorgasbord of recommended soft-law AI ethical practices and patchwork hard-law AI laws that are springing up throughout the states. Furthermore, our lawmakers should be wisely eyeing the globally emerging AI soft-laws and AI hard-laws that are available for the world to see and reuse.
Make no mistake, all of this is a burgeoning part of the law and growth is abundant.
Attorneys and law students will soon see that AI & Law is bubbling up to the surface. As more AI is devised and unleashed, companies and governments will need to seek out savvy AI-aware legal advisors. Meanwhile, the coming glut of new or imagined AI laws will require legal minds that can ensure that the laws as codified are sensible and practical. And the potential harms produced by AI will require lawyers that are willing to fight for humankinds rights against the blitz of dour AI systems.
Per the wisdom of Louis Brandeis, former Associate Justice of the U.S. Supreme Court: If we desire respect for the law, we must first make the law respectable.
Lets all get into the action and make humankinds rights associated with the advent of AI a top priority. It assuredly seems like a respectable thing to do.
About The Author
Dr. Lance Eliot is a global expert on AI & Law and serves as a Stanford Fellow affiliated with the Stanford Law School (SLS) and the Stanford Computer Science Department via the Center for Legal Informatics. His popular books on AI & Law are highly rated and he has been an invited keynote speaker at major law industry conferences. His articles have appeared in numerous legal publications includingMIT Computational Law Journal, Robotics Law Journal, The AI Journal, Computers & Law Journal, Oxford University Business Law (OBLB), New Law Journal, The Global Legal Post, Lawyer Monthly, Legal Business World, LexQuiry, The Legal Daily Journal, Swiss Chinese Law Review Journal, The Legal Technologist, Law360, Attorney At Law Magazine, Law Society Gazette, and others. Dr. Eliot serves on AI & Law committees for the World Economic Forum (WEF), United Nations ITU, IEEE, NIST, and other standards boards, and has testified for Congress on emerging AI high-tech aspects. He has been a professor at the University of Southern California (USC) and served as the Executive Director of a pioneering AI research lab at USC. He has been a top executive at a major Venture Capital (VC) firm, served as a corporate officer in several large firms, and been a highly successful entrepreneur.
Acknowledgment
This research is part of an ongoing initiative on AI & Law and thanks go to the Stanford University CodeX Center for Legal Informatics, a center jointly operated by the Stanford Law School (SLS) and the Stanford Computer Science Department. CodeX s emphasis is on the research and development of computational lawthe branch of legal informatics concerned with the automation and mechanization of legal analysis.
Suggested citation: Lance Eliot, U.S. Releases An AI Bill Of Rights That Though Encouraging Wont Yet Move The Needle, JURIST Academic Commentary, October 5, 2022, https://www.jurist.org/commentary/2022/10/u-s-releases-an-ai-bill-of-rights-that-though-encouraging-wont-yet-move-the-needle/.
This article was prepared for publication by Ingrid Burke-Friedman, Features Editor. Please direct any questions or comments to her at commentary@jurist.org
Opinions expressed in JURIST Commentary are the sole responsibility of the author and do not necessarily reflect the views of JURIST's editors, staff, donors or the University of Pittsburgh.
Read the original here:
U.S. Releases an AI Bill Of Rights That Though Encouraging Won't Yet Move the Needle - JURIST
- The Ethical, Legal, and Social Issues Impacted by Modern ... - Hindawi - November 25th, 2022
- BSGM - The British Society for Genetic Medicine - November 25th, 2022
- Feasibility and ethics of using data from the Scottish newborn blood spot archive for research | Communications Medicine - Nature.com - October 7th, 2022
- Closing your health care practice: What you need to know - Medical Economics - October 7th, 2022
- Is the doctor's office heading for extinction? - Medical Economics - October 7th, 2022
- Abortion Access in the U.S.: What to Know on a State-By-State Level - Healthline - October 7th, 2022
- Students can create their own path with new ASU Online biology degree - ASU News Now - October 7th, 2022
- California Funds Research On Blocking Marijuana Monopolies And Protecting 'Legacy' Cannabis Strains - Marijuana Moment - October 7th, 2022
- Tips For Your Virtual Meetings With The FDA - Med Device Online - October 7th, 2022
- Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed ... - The Bakersfield Californian - October 7th, 2022
- MeiraGTx Announces the Upcoming Presentation of 15 Abstracts at the European Society of Gene and Cell Therapy (ESGCT) 2022 Annual Congress -... - October 7th, 2022
- Neighborhood deprivation and coronary heart disease in patients with bipolar disorder | Scientific Reports - Nature.com - October 7th, 2022
- Have Insurers Paid Too Much for Asbestos and Other Toxic Torts? - Claims Journal - August 19th, 2022
- Restrictive abortion laws are limiting the options parents have after receiving genetic test results, experts say - Yahoo Singapore News - August 19th, 2022
- Neurologists Discuss the Impact of Roe v. Wade Reversal on... : Neurology Today - LWW Journals - August 19th, 2022
- Abortion ruling prompts variety of reactions from states - ABC News - August 19th, 2022
- Is pregnancy possible after multiple failed IVF attempts? Can your frozen eggs and sperm be as healthy later? - The Indian Express - August 19th, 2022
- Meet the Expert: Focus on orthopaedics and VTE - Hospital Healthcare Europe - August 19th, 2022
- Egg Donation Process: From Application to Recovery - Healthline - July 6th, 2021
- Patent protection of mRNA vaccines and regulatory authorization - Lexology - July 6th, 2021
- EAPM: Presidency bridging conference a great success, HTA compromise agreed and data on the agenda - EU Reporter - July 6th, 2021
- Cell and Gene Therapy Drug Delivery Devices Market, 2030 - Market Opportunities in the Strong Pipeline of Cell and Gene Therapies - PRNewswire - April 4th, 2021
- Legally blind Great Falls filmmakers share their vision in national challenge - Yahoo News - April 4th, 2021
- Pfizer Announces Vaccine Is 100% Protective Against Coronavirus In Kids As Young As 12 - Yahoo News - April 4th, 2021
- How the law will change in 2021 - Lexology - February 11th, 2021
- Writing is the best medicine - The London Economic - February 11th, 2021
- Misleading glyphosate-cancer study Part 2: 'Symptom of a widespread problem'Concerns about ideological activism in science research and communications... - February 11th, 2021
- The Error of Fighting a Public Health War With Medical Weapons - WIRED - January 2nd, 2021
- Moderna, Pfizer vaccine trials were the highest of quality: vaccine expert - Yahoo Money - January 2nd, 2021
- Celebrate the new year with this New Year's Eve fireworks show in SF - Yahoo News - January 2nd, 2021
- The movie industry will strengthen again around April or May: Screenvision CEO - Yahoo Money - January 2nd, 2021
- Congress overrides Donald Trump's veto of a defense policy bill in the first such rebuke of his presidency - Yahoo News - January 2nd, 2021
- How the pandemic enabled a robot revolution - Politico - December 4th, 2020
- The mink link: How COVID-19 mutations in animals affect human health and vaccine effectiveness - The Conversation CA - November 24th, 2020
- How vaccines get made and approved in the US - The Albany Herald - November 24th, 2020
- Legalization votes bring worries of increased youth marijuana use, but evidence remains murky - AberdeenNews.com - November 24th, 2020
- Your daily 6: Third vaccine looks effective, no single 'word of the year' and Trump team called 'a national embarrassment' - Ravalli Republic - November 24th, 2020
- Cybersecurity depends on the user - Modern Diplomacy - November 20th, 2020
- It's Been Exactly One Year Since the First Case of COVID Was Found in China - Newsweek - November 20th, 2020
- Risks and benefits of an AI revolution in medicine - Harvard Gazette - November 12th, 2020
- HHS eased oversight of Covid-19 tests though it knew of problems - STAT - November 3rd, 2020
- Who won this years Nobel science prizes? - The Economist - October 8th, 2020
- Patent and Patient Rights in COVID-19: Is the Right to Exclusivity a Hamlet Question? - The Leaflet - October 8th, 2020
- FDA Oversight of Laboratory-Developed Tests Continues To Evolve - JD Supra - October 8th, 2020
- One Sperm Donor. 36 Children. A Mess of Lawsuits. - The Atlantic - September 15th, 2020
- Nebraska Medical Bill initiative blocked from entering the November ballots - Cannabis Health Insider - September 15th, 2020
- Poaching pressure mounts on jaguars, the Americas' iconic big cat - Mongabay.com - September 15th, 2020
- 'There is a sense of being robbed': Olympian Caster Semenya loses appeal on testosterone rule - The World - September 15th, 2020
- Global Microbiome Sequencing Market Growth Drivers, Demands, Business Opportunities and Demand Forecast to 2026|Clinical-Microbiomics A/S; Diversigen;... - September 5th, 2020
- Legal and Regulatory Issues in Genetic Information ... - August 31st, 2020
- The legal aspects of genetic testing - Medical Defence Union - August 31st, 2020
- Their view: Now is not the time to legalize marijuana - Wilkes Barre Times-Leader - August 31st, 2020
- Weighing up the potential benefits and harms of comprehensive full body health checks - Croakey - August 24th, 2020
- Soon, India will have its dedicated vaccine portal: ICMR - ETHealthworld.com - August 24th, 2020
- Two Families, Two Fates: When the Misdiagnosis is Child Abuse - The Marshall Project - August 22nd, 2020
- Ron Evans steals a trick from I/O, and points the way to a transformational diabetes therapy - Endpoints News - August 22nd, 2020
- Contact tracing apps may be ineffective for reducing Covid-19 spread: Study - ETHealthworld.com - August 22nd, 2020
- Global Microbiome Sequencing Market Size 2020 Review, Growth Strategy, Developing Technologies And Forecast By 2026|Charles River; CoreBiome, Inc.;... - August 19th, 2020
- Bill Jones: Working to create a culture of education - Wilkes Barre Times-Leader - August 19th, 2020
- Whats next for abortion legislation in the U.S.? - PBS NewsHour - July 10th, 2020
- No ethics when it comes to US enemies, even in the middle of a deadly pandemic - IOL - July 10th, 2020
- IML conducts the 5th National Convention on Medicine and Law - ETHealthworld.com - July 10th, 2020
- Wayne Medicine and Wayne Law professors team up to explore legal and ethical issues of wastewater monitoring for COVID-19 - The South End - June 28th, 2020
- Challenge trials aren't the answer to a speedy Covid-19 vaccine - STAT - June 28th, 2020
- Trump Suspends H-1B and Other Visas That Allow Foreigners to Work in the U.S. - The New York Times - June 24th, 2020
- Could the Montreal Neuro herald a paradigm shift in scientific research? - University Affairs - June 24th, 2020
- Next-Generation Sequencing Market: Understanding The Key Product Segments And Their Future During 2020 -2025 - 3rd Watch News - June 24th, 2020
- Meet 'Gastruloid': The First Human Embryo-like Model From Stem Cells That Could Soon Save Many Babie - Science Times - June 12th, 2020
- Could these senolytic drugs halt the spread of COVID-19? - Health Europa - June 12th, 2020
- The coronavirus vaccine frontrunners have emerged. Here's where they stand - BioPharma Dive - June 12th, 2020
- Regulating marine genetic resources in areas beyond national jurisdiction - The Daily Star - June 12th, 2020
- Vaccines have saved millions of lives, but history shows missteps can prove deadly - The Boston Globe - June 12th, 2020
- Quitting smoking might reduce severe coronavirus infection risk: Study - ETHealthworld.com - May 23rd, 2020
- Where Taiwan Can Make the Most of AI - Taiwan - Taiwan Business TOPICS - May 23rd, 2020
- WHO and IOC team up to improve health through sport - ETHealthworld.com - May 18th, 2020
- The Cell Therapy Industry to 2028: Global Market & Technology Analysis, Company Profiles of 309 Players (170 Involved in Stem Cells) -... - May 15th, 2020
- Medical School: Who gets in and why - Stuff.co.nz - May 15th, 2020
- Wilson Ighodalo: Addressing Substance Abuse as a Public Health Problem - THISDAY Newspapers - May 15th, 2020
- The Falsehoods of the 'Plandemic' Video - FactCheck.org - May 14th, 2020
- Robert Youngjohns, Chairman of the Board, ABBYY - Interview Series - Unite.AI - May 14th, 2020